Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr. Reddy’s Laboratories informs about press release

Date: 20-01-2023

Dr. Reddy’s Laboratories has informed that it enclosed a Press Release on ‘Dr. Reddy’s successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe’.

The above information is a part of company’s filings submitted to BSE.